SCTB41

DRUG4 trials

Sponsors

Sinocelltech Ltd.

Conditions

Advanced Malignant Solid TumoursDouble BlindNHL - Non-Hodgkin's LymphomaNSCLC (Advanced Non-small Cell Lung Cancer)

Phase 1

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.

RecruitingNCT06600022

Sinocelltech Ltd.Advanced Malignant Solid Tumours

Start: 2024-10-10End: 2028-04-30Target: 441Updated: 2025-01-16

SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma

Not yet recruitingNCT07819188

Sinocelltech Ltd.NHL - Non-Hodgkin's Lymphoma

Start: 2026-09-30End: 2029-09-30Target: 90Updated: 2026-09-14

Phase 2

A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing）

Not yet recruitingNCT07609251

Sinocelltech Ltd.NSCLC (Advanced Non-small Cell Lung Cancer)

Start: 2026-05-01End: 2029-07-01Target: 90Updated: 2026-05-27

SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

RecruitingNCT07662395

Sinocelltech Ltd.Double Blind

Start: 2026-05-09End: 2030-01-24Target: 410Updated: 2026-06-23